UNSPSC 85445405: The diagnosis of butyrophenone and thioxanthene neuroleptics

In this classification, this covers the group of activities that yields a diagnosis of butyrophenone and thioxanthene neuroleptics. Butyrophenone and thioxanthene neuroleptics is listed In The World Health Organization's International Statistical Classification of Diseases and Related Health Problems (ICD-10) as a four-character category under code Y49.4.

UNSPSC 85445405 Diagnosis of butyrophenone and thioxanthene neuroleptics is a Commodity code with little recent state and local procurement activity aligned to its nominal scope. The three most recent opportunities posted under this code—a diagnostic imaging PACS system procurement from San Mateo Medical Center, a special education contracted services request from Birdville Independent School District, and a temporary health professional staffing qualification vehicle from Santa Clara County Health System—bear no clear relationship to the neuropsychiatric pharmaceutical diagnostic services the code describes. The mismatch suggests either misclassification by the issuing bodies or a code that sees minimal use in state and local contracting for its intended purpose.

The geographic activity reflected in these records spans California (San Mateo County, Santa Clara County) and Texas (Tarrant County), but the opportunities themselves do not represent procurement under the code's stated scope. State and local procurement professionals evaluating this code should verify whether recent postings have been miscoded or whether demand for butyrophenone and thioxanthene neuroleptic diagnostic services through state and local channels is genuinely sparse. A clearer signal would emerge from reviewing prior fiscal years or consulting directly with the health system procurement offices that posted these opportunities to determine whether they recoded after posting or whether the code itself sees limited application in public health procurement.